Income Taxes - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Change in valuation allowance	$ 315,000	$ 2,831,000
Capitalized research and development costs	14,785,000	11,530,000	$ 3,255,000
Operating loss carryforwards	37,323,000
Income tax expense (benefit)	$ 0	$ 0	$ 0